Repeating the avidin “chase” markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity
- 30 September 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (10) , 1689-1696
- https://doi.org/10.1016/0959-8049(95)00244-d
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibodyZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Scintigraphic detection of xenografted tumors producing human basic fibroblast growth factorCancer Immunology, Immunotherapy, 1993
- In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibodyNuclear Medicine and Biology, 1993
- Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodiesInternational Journal of Cancer, 1990
- Identification of a human osteosarcoma-associated glycoprotein with monoclonal antibodies: relationship with alkaline phosphataseBiochemistry and Cell Biology, 1987
- Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.Radiology, 1987
- A Spectrophotometric Assay for Avidin and Biotin Based on Binding of Dyes by AvidinBiochemical Journal, 1965
- THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITYBiochemical Journal, 1963
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962